STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)
CUSIP: 34385P108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 384,731,503
- Total 13F shares
- 271,250,577
- Share change
- +5,834,220
- Total reported value
- $480,012,531
- Put/Call ratio
- 9.6%
- Price per share
- $1.77
- Number of holders
- 142
- Value change
- -$2,577,119
- Number of buys
- 72
- Number of sells
- 68
Quarterly Holders Quick Answers
What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34385P108:
Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Casdin Capital, LLC |
13F
|
Company |
16%
|
61,907,605
|
$167,769,610 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
3/4/5
|
Company · 10%+ Owner |
15%
|
58,651,170
|
$158,944,671 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.7%
|
14,373,199
|
$38,951,369 | — | 31 Mar 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
3.4%
|
13,042,440
|
$35,345,012 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
13,034,043
|
$35,322,256 | — | 31 Mar 2024 | |
| Caligan Partners LP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
16,265,374
mixed-class rows
|
$34,539,714 | — | 29 Jun 2023 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.3%
|
8,853,491
|
$23,992,961 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.3%
|
8,853,491
|
$23,992,961 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
7,617,876
|
$20,644,448 | — | 31 Mar 2024 | |
| Indaba Capital Management, L.P. |
13F
|
Company |
1.9%
|
7,363,064
|
$19,953,903 | — | 31 Mar 2024 | |
| Tikvah Management LLC |
13F
|
Company |
1.7%
|
6,551,058
|
$17,753,367 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
5,450,229
|
$14,770,122 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.3%
|
4,845,051
|
$13,130,088 | — | 31 Mar 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
1.2%
|
4,744,923
|
$12,852,900 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1%
|
3,953,820
|
$10,714,853 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
3,277,713
|
$8,882,602 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.79%
|
3,021,843
|
$8,189,195 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
2,706,926
|
$7,337,851 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.54%
|
2,095,091
|
$5,677,697 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.49%
|
1,883,179
|
$5,103,415 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.45%
|
1,716,967
|
$4,652,981 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.43%
|
1,670,401
|
$4,526,787 | — | 31 Mar 2024 | |
| Slate Path Capital LP |
13F
|
Company |
0.42%
|
1,615,000
|
$4,376,650 | — | 31 Mar 2024 | |
| Magnetar Financial LLC |
13F
|
Company |
0.39%
|
1,515,390
|
$4,106,707 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.36%
|
1,383,697
|
$3,749,819 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.35%
|
1,341,357
|
$3,635,077 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
1,266,859
|
$3,433,188 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
1,253,858
|
$3,398,000 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.32%
|
1,229,288
|
$3,331,369 | — | 31 Mar 2024 | |
| NEEDHAM INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.29%
|
1,124,435
|
$3,047,219 | — | 31 Mar 2024 | |
| Jennifer C. Price |
13F
|
Individual |
0.25%
|
980,100
|
$2,656,071 | — | 31 Mar 2024 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
0.22%
|
855,145
|
$2,317,443 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
784,928
|
$2,127,154 | — | 31 Mar 2024 | |
| METEORA CAPITAL, LLC |
13F
|
Company |
0.18%
|
677,100
|
$1,834,941 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.18%
|
676,176
|
$1,832,437 | — | 31 Mar 2024 | |
| Gagnon Advisors, LLC |
13F
|
Company |
0.17%
|
672,294
|
$1,821,917 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.17%
|
646,940
|
$1,753,207 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
636,339
|
$1,724,479 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
592,646
|
$1,606,071 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.15%
|
578,439
|
$1,567,570 | — | 31 Mar 2024 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
0.14%
|
550,000
|
$1,490,500 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.13%
|
507,417
|
$1,375,000 | — | 31 Mar 2024 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
0.13%
|
505,535
|
$1,370,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
483,944
|
$1,311,488 | — | 31 Mar 2024 | |
| Bradley & Co. Private Wealth Management, LLC |
13F
|
Company |
0.12%
|
447,877
|
$1,213,747 | — | 31 Mar 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.11%
|
441,572
|
$1,196,660 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.11%
|
441,232
|
$1,195,739 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
428,660
|
$1,161,669 | — | 31 Mar 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.11%
|
426,200
|
$1,155,002 | — | 31 Mar 2024 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.11%
|
423,518
|
$1,147,734 | — | 31 Mar 2024 |
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2024
As of 30 Jun 2024,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
271,250,577 shares.
The largest 10 holders included
Casdin Capital, LLC, VIKING GLOBAL INVESTORS LP, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Tikvah Management LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
144
Q2 2024 holders
142
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.